Abvc Biopharma (ABVC) Leases (2019 - 2025)
Historic Leases for Abvc Biopharma (ABVC) over the last 7 years, with Q3 2025 value amounting to $369135.0.
- Abvc Biopharma's Leases fell 2728.68% to $369135.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $369135.0, marking a year-over-year decrease of 2728.68%. This contributed to the annual value of $640387.0 for FY2024, which is 2086.98% down from last year.
- Per Abvc Biopharma's latest filing, its Leases stood at $369135.0 for Q3 2025, which was down 2728.68% from $459325.0 recorded in Q2 2025.
- Abvc Biopharma's 5-year Leases high stood at $1.7 million for Q1 2021, and its period low was $369135.0 during Q3 2025.
- Over the past 5 years, Abvc Biopharma's median Leases value was $999645.0 (recorded in 2023), while the average stood at $1.0 million.
- Per our database at Business Quant, Abvc Biopharma's Leases skyrocketed by 32716.3% in 2021 and then plummeted by 4358.2% in 2024.
- Abvc Biopharma's Leases (Quarter) stood at $1.5 million in 2021, then decreased by 21.11% to $1.2 million in 2022, then crashed by 30.3% to $809283.0 in 2023, then dropped by 20.87% to $640387.0 in 2024, then tumbled by 42.36% to $369135.0 in 2025.
- Its last three reported values are $369135.0 in Q3 2025, $459325.0 for Q2 2025, and $533460.0 during Q1 2025.